---
document_datetime: 2023-09-21 18:46:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rienso-epar-all-authorised-presentations_en.pdf
document_name: rienso-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.971921
conversion_datetime: 2025-12-21 19:20:37.887545
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Package size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|----------------|
| EU/1/12/774/001  | Rienso            | 30 mg/ml   | Solution for infusion | Intravenous use           | Vial (glass)          | 17 ml                     | 1 vial         |
| EU/1/12/774/002  | Rienso            | 30 mg/ml   | Solution for infusion | Intravenous use           | Vial (glass)          | 17 ml                     | 10 vials       |
| EU/1/12/774/003  | Rienso            | 30 mg/ml   | Solution for infusion | Intravenous use           | Vial (glass)          | 17 ml                     | 2 vials        |
| EU/1/12/774/004  | Rienso            | 30 mg/ml   | Solution for infusion | Intravenous use           | Vial (glass)          | 17 ml                     | 6 vials        |

Medicinal product no longer authorised